α-synuclein-IN-16
α-synuclein-IN-16 (Compound H1) is a α-synuclein inhibitor. α-synuclein-IN-16 significantly inhibits the secondary nucleation in α-synuclein aggregation. α-synuclein-IN-16 can be used for Parkinson’s disease research[1].
Product Specifications
UNSPSC
12352005
Target
α-synuclein
Related Pathways
Neuronal Signaling
Field of Research
Neurological Disease
Smiles
C[C@@H]1CC(C2=C3C(C4=C([C@@H]([C@@]3([C@@H]([C@@H]5OC([C@H]6CCCN6[C@@]25C1)=O)O)O)O)C(O)=CC=C4)=O)=O
Molecular Formula
C24H25NO8
Molecular Weight
455.46
References & Citations
[1]Zhang H, et al. Structure-based Generation of a Secondary Nucleation Inhibitor in alpha-Synuclein Aggregation Using a Conditional Diffusion Model[J]. bioRxiv, 2025: 2025.08. 16.670694.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
